Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 802. The contact email is not on this page.
- OSEL, INC.
NIH R43: Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus iners
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TRULY TECHNOLOGIES LLC
NIH R43: Enabling standardized point-of-care tuberculosis diagnostics via rapid osmotic concentration
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MCM6 THERAPEUTICS, INC.
NIH R41: High-Content Screen to Identify Small Molecule Therapeutics that Reduce Aberrant Lipid Accumulation in APOE4 Alzheimer's Disease
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VONA ONCOLOGY, LLC
NIH R44: VDX-111: A novel targeted therapeutic for triple-negative breast cancer
startup · CO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ONCOTHERAPY SOLUTIONS, LLC
NIH R43: Stable, highly potent and safe lead peptide drug conjugate for the treatment of triple-negative breast cancer.
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Acomhal Research, Inc.
Form D history: Biotechnology
startup · VA · amount not stated · 2021-04-20
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2021-04-20.
- ESK THERAPEUTICS, INC
NIH R43: Commercialization of a Biologic Eyedrop for Persistent Corneal Epithelial Defects
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GLUCOSENTIENT, INC.
NIH R43: Improving the effectiveness of anti-tuberculosis drugs by developing a point-of-care therapeutic drug monitoring system for areas with limited medical resources
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SILPHION LIFE SCIENCES, INC
NIH R43: Small Molecule Notch Agonist as a Therapeutic for Liver Disease in Alagille Syndrome
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MCC HEALTH, INC
NIH R41: Improving patient outcomes through a digital health delivered intervention to monitor and manage symptoms after chimeric antigen receptor T-cell therapy
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CANCER TARGETED TECHNOLOGY, LLC
NIH R44: Development of an Innovative PSMA-Targeted Small Molecule Prodrug for Prostate Cancer
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ONCURIE INC.
NIH R41: A novel platform for targeted radiopharmaceuticals for imaging and therapy of ovarian cancer
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OSCILLOSCAPE, LLC
NIH R43: SynG: a Music-Based Intervention for Alzheimer's and Mild Cognitive Impairment
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RESPANA THERAPEUTICS, INC.
NIH R42: Treatment of Inflammatory Complications of Respiratory Infection
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRO THERAPEUTICS LLC
NIH R44: Development of a Novel Engineered Tendon Graft to Assist in Repair of Rotator Cuff Injuries
startup · NH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PANORAMA RESEARCH, INC.
NIH R43: Novel Therapy for Sarcopenia
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEPHROPATHOLOGY ASSOCIATES
NIH R44: A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases
startup · AR · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Aquinnah Pharmaceuticals
Aquinnah Pharmaceuticals is a biotechnology company focused on developing treatments for neurodegenerative diseases such as Alzheimer's and ALS. The company specializes in creating small molecule therapeutics that aim to modulate stress granules and reduce tau pathology.
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EINSENCA INC.
NIH R44: PET Imaging of Damaging Neuroinflammation in Alzheimer's Disease Technical and Business Assistance (TABA)
startup · DE · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Keliomics, Inc.
Form D history: Biotechnology
startup · OR · amount not stated · 2023-11-30
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-11-30.
- SENSORIIS, INC.
NIH R41: Novel Acquisition and Computation of Cardiac Functions in Developing Zebrafish Embryos
startup · WA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Capsulomics, LLC
Form D history: Biotechnology
startup · MD · amount not stated · 2025-03-19
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2025-03-19.
- CALLENTIS CONSULTING GROUP LLC
NIH R41: AI Platform to Discover Therapeutics for Substance Use Disorders
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PERCEPTION DYNAMICS INSTITUTE
NIH R43: Retraining Neural Pathways to Improve Cognitive Skills after a Mild Traumatic Brain Injury (mTBI)
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VITALEX BIOSCIENCES, LLC
NIH R44: Humanized monoclonal antibodies to treat mucormycosis
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEDCHEM PARTNERS, LLC
NIH R41: Combating Corneal HSV Infection with Novel Dynasore Analogues
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PASCALL SYSTEMS, INCORPORATED
NIH R44: Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AQUILLIUS CORPORATION
NIH R43: Wearable Graphene Respiratory Sensor for Early Detection and Monitoring of Asthma
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RESCUE BIOMEDICAL, LLC
NIH R43: User-Centric Development of a Detection Module for a Closed-Loop Solution to Opioid Overdose
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VIRGINIA DIODES, INC.
NIH R43: Solid-State Sources for DNP-NMR
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- STEM PHARM, INC.
NIH R43: Development and Validation of a CNS Organoid Model of Temporal Lobe Epilepsy for Drug Discovery
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LEBRUN LABS, LLC
NIH R44: An In Chemico Test to Identify Dermal Corrosives
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ONE HEALTH STUDIO LLC
NIH R44: Flourish All: Women's Integrated Stress Reduction for Alzheimer's Risk Prevention Using Digital Tools and Biomarker Monitoring
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PULSEIMAGING.AI, LLC
NIH R41: Cardiovascular risk prediction from AI analysis of coronary calcifications
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MONTANI BIOTECHNOLOGIES, INC
NIH R43: Optimization of mRNA genetic adjuvant for immunotherapy
startup · WV · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NAVINETICS NEUROMODULATION, INC.
NIH R42: An Integrated Neurochemical/Electrophysiological Recording and Neuromodulation System for Basic and Clinical Research
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CHRONONAI, LLC
NIH R41: Development of a Foundation Model for Live Cell Phenotyping to Transform Cancer Research and Therapy
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.
NIH R42: Affordable sialoglycans and associated reagents for expanded chemoenzymatic production
startup · SC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LC ACQUISITION LLC
NIH R43: Miniature Ion Mobility Detector for Compact Liquid Chromatographic Analysis of Novel Psychoactive Substances
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AXCEND, LLC
Form D history: Other Technology
startup · UT · amount not stated · 2023-02-23
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-02-23.